Oxygenta Pharmaceutical Ltd
BSE: 524636
Shareholding Trends
Ownership split
Institutional detail
Q1 FY27
Corporate Events
Board Meeting
The Board Meeting is scheduled to consider and approve the u…
BSE Filing ↗Board Meeting
Notice of the 33rd Annual General Meeting for the Financial …
BSE Filing ↗Board Meeting
The Board Meeting is scheduled to consider and approve the U…
BSE Filing ↗Board Meeting
The board meeting is scheduled to consider and approve the a…
BSE Filing ↗Board Meeting
Consider and approve audited financial results of the Fourth…
BSE Filing ↗Board Meeting
Consider and approve This is to inform you .... 2015 and all…
BSE Filing ↗Board Meeting
Consider and approve This is to inform you .... Oxygenta Pha…
BSE Filing ↗Board Meeting
Consideration and approval of raising of funds by way of iss…
BSE Filing ↗Board Meeting
Consideration and approval of Un Audited Financial Results f…
BSE Filing ↗Board Meeting
To consider and approve the Un Audited Financial Results for…
BSE Filing ↗Board Meeting
consider and approve the Un Audited Financial Results of the…
BSE Filing ↗